Table 4.
Cross-classification of participants for cardiovascular disease risk by both AHA/CDC (hsCRP) criteria and Framingham risk categories for the 521 participants without self-reported CVD.
| Framingham Risk Category | |||||||
|---|---|---|---|---|---|---|---|
| Osteoarthritis Unaffected (N, column %) | Osteoarthritis Affected (N, column %) | ||||||
| Low (N=90) | Moderate (N=86) | High (N= 57) | Low (N=93) | Moderate (N=119) | High (N=76) | ||
| AHA/CDC Risk Category | Low Risk | 43 (48%) | 36 (42%) | 12 (21%) | 29 (31%) | 30 (25%) | 20 (26%) |
| Moderate Risk | 20 (22%) | 27 (31%) | 17 (30%) | 21 (23%) | 24 (20%) | 21 (28%) | |
| High Risk | 27 (30%) | 23 (27%) | 28 (49%) | 43 (46%) | 65 (55%) | 35 (46%) | |
Framingham Risk Category:10-year cardiovascular risk category defined as Low <10% Risk, Moderate 10–20% Risk, and High >20% Risk based upon Grundy et. al., 200416.
AHA/CDC Risk Category: American Heart Association and Centers for Disease Control and Prevention cardiovascular disease risk categories based upon hsCRP and defined as Low hsCRP < 1 mg/L, Moderate hsCRP 1–3 mg/L, and High hsCRP > 3 mg/L Risk based upon Pearson et. al., 200317.
hsCRP = high-sensitivity C-reactive protein in serum